HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer

被引：0
|
作者：
Garyfallia Pantelaiou-Prokaki
Iga Mieczkowska
Geske E. Schmidt
Sonja Fritzsche
Evangelos Prokakis
Julia Gallwas
Florian Wegwitz
机构：
[1] University Medical Center Göttingen,Department of Gynecology and Obstetrics
[2] Max Planck Institute for Experimental Medicine,Translational Molecular Imaging
[3] University Medical Center Göttingen,Department of General, Visceral and Pediatric Surgery
[4] University Medical Center Göttingen,Department of Gastroenterology, GI
来源：
Clinical Epigenetics | 2022年 / 14卷
关键词：
HDAC8; MET; EMT; BLBC; TNBC; Chemotherapy; Epigenetics; H3K27ac; Epithelial transcription factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer
    Qing-Shan Wang
    Peng-Zhou Kong
    Xiao-Qing Li
    Fan Yang
    Yu-Mei Feng
    Breast Cancer Research, 17
  • [22] Nestin expression is associated with a basal-like phenotype and poor prognosis in breast cancer
    Krueger, Kristi
    Wik, Elisabeth
    Klingen, Tor Audun
    Chen, Ying
    Aas, Turid
    Akslen, Lars A.
    CANCER RESEARCH, 2016, 76
  • [23] The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
    Fedele, Monica
    Cerchia, Laura
    Chiappetta, Gennaro
    CANCERS, 2017, 9 (10)
  • [24] Effect of anti-DR5 and chemotherapy on basal-like breast cancer
    Patsy G. Oliver
    Albert F. LoBuglio
    Tong Zhou
    Andres Forero
    Hyunki Kim
    Kurt R. Zinn
    Guihua Zhai
    Yufeng Li
    Choo H. Lee
    Donald J. Buchsbaum
    Breast Cancer Research and Treatment, 2012, 133 : 417 - 426
  • [25] Effect of anti-DR5 and chemotherapy on basal-like breast cancer
    Oliver, Patsy G.
    LoBuglio, Albert F.
    Zhou, Tong
    Forero, Andres
    Kim, Hyunki
    Zinn, Kurt R.
    Zhai, Guihua
    Li, Yufeng
    Lee, Choo H.
    Buchsbaum, Donald J.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) : 417 - 426
  • [26] Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition
    Kalogris, Cristina
    Garulli, Chiara
    Pietrella, Lucia
    Gambini, Valentina
    Pucciarelli, Stefania
    Lucci, Cristiano
    Tilio, Martina
    Zabaleta, Maria Elexpuru
    Bartolacci, Caterina
    Andreani, Cristina
    Giangrossi, Mara
    Iezzi, Manuela
    Belletti, Barbara
    Marchini, Cristina
    Amici, Augusto
    BIOCHEMICAL PHARMACOLOGY, 2014, 90 (03) : 226 - 234
  • [27] BASAL-LIKE PHENOTYPE IS A PROGNOSTIC MARKER OF LOCALLY ADVANCED BREAST CANCER BUT NOT A PREDICTIVE MARKER OF RESPONSE TO NEOADJUVANT ANTHRACYCLINE CHEMOTHERAPY
    Shehata, M.
    Mukherjee, A.
    Moseley, P.
    Rakha, E.
    Ellis, I.
    Chan, S.
    EJC SUPPLEMENTS, 2010, 8 (06): : 11 - 11
  • [28] AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program
    Wu, Xuebiao
    Li, Xiaoli
    Fu, Qiang
    Cao, Qianhua
    Chen, Xingyu
    Wang, Mengjie
    Yu, Jie
    Long, Jingpei
    Yao, Jun
    Liu, Huixin
    Wang, Danping
    Liao, Ruocen
    Dong, Chenfang
    JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (04): : 1065 - 1079
  • [29] Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer
    Rodriguez-Pinilla, Socorro M.
    Sarrio, David
    Moreno-Bueno, Gema
    Rodriguez-Gil, Yolanda
    Martinez, Miguel A.
    Hernandez, Lucia
    Hardisson, David
    Reis Filho, Jorge S.
    Palacios, Jose
    MODERN PATHOLOGY, 2007, 20 (04) : 474 - 481
  • [30] Claudin-Low Breast Cancer: A Novel Subtype Associated with Basal-Like Phenotype and Metaplastic Breast Cancer
    Lu, S.
    Singh, K.
    Mangray, S.
    Tavares, R.
    Noble, L.
    DeLellis, R. A.
    Resnick, M.
    Yakirevich, E.
    LABORATORY INVESTIGATION, 2011, 91 : 52A - 53A
12345